Opiant Pharmaceuticals, INC.
SEC CIK 1385508 · OPNT · last insider filing 2023-03-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Collard Craig A | Director | filed 2018–2023 |
| Lorianne Masuoka K. | Director | filed 2021–2023 |
| Sinclair Michael | Director · Executive Chairman | filed 2012–2023 |
| Daly Richard J | Director | filed 2018–2023 |
| Crystal Roger | Director · Chief Executive Officer | filed 2015–2023 |
| Silver Gabrielle Alison | Director | filed 2016–2023 |
| Macdougall Ann L. | Director | filed 2016–2023 |
| Thomas Thomas T. | Director | filed 2016–2023 |
| Wolf Geoffrey | Director | filed 2015–2018 |
| Pollack Kevin | Director · See Remarks | filed 2012–2017 |
| Ki Seijin | Director | filed 2010–2010 |
| Meuse Joseph J | Director | filed 2009–2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Skolnick Phil | Chief Scientific Officer | filed 2017–2023 |
| O'Toole David D | Chief Financial Officer | filed 2017–2023 |
| Ellison Mark Jason Heath | Chief Development Officer | filed 2019–2023 |
| Ruth Matthew R. | Chief Commercial Officer | filed 2021–2023 |
| Mottiwala Aziz | Chief Commercial Officer | filed 2019–2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.